skip to main content

Contact us to get started

Hope begins here.

If you're an HR or benefits professional seeking cancer resources for your employees, or a consultant looking to provide best-in-class cancer support for your clients, share a few details below. We’ll reach out to help your company get started.

If you’re an employee looking for your AccessHope benefit, call 800.423.3232 and select Option 1.

Unmatched expertise in the fight against cancer

You want the best for your clients and their employees facing cancer and that starts with access to the latest knowledge.

Outcomes are dramatically better at National Cancer Institute (NCI)-Designated Comprehensive Cancer Centers, but only 20% of cases are treated there.1,2 That’s why AccessHope makes it easy to bring the latest expertise to employees by connecting their local oncologists with NCI subspecialists.

We proudly partner with NCI centers to remotely deliver expertise to employees and their families nationwide

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Read More

Fred Hutch Cancer Center

Fred Hutch Cancer Center

Read More

Johns Hopkins Medicine

Kimmel Cancer Center

Read More

Northwestern Medicine

Northwestern Medicine

Read More

UT Southwestern Medical Center

Harold C. Simmons Comprehensive Cancer Center

Read More
Asset 16-final

Cancer isn’t one disease

We now know there are hundreds of cancer types and variants, and optimal treatments can be radically different depending on factors like genetics and stage. AccessHope supports your clients’ employees and their oncologists with expertise related to their specific case, to make a real, measurable, tangible difference.

Asset 15-final

Cancer is costing your clients

Cancer is the top driver of complex care costs. In one year, cancer care can cost employers $103.8 billion, plus $123 billion in absenteeism and lost productivity.3,4 AccessHope can reduce expenses that result from a lack of access to the latest knowledge, including unnecessary testing and inappropriate treatments. It also saves employees unnecessary physical and emotional strain caused by these treatments.
Asset 14-final

Cancer research isn’t reaching everyone

Cancer research is evolving rapidly, but that doesn’t mean it’s reaching everyone equally. Cancer treatments and outcomes can vary by zip code, race, ethnicity, socioeconomic status, sexual orientation and more.4 AccessHope allows your clients to ensures NCI expertise is available to every employee facing a cancer diagnosis, no matter who they are or where they live.

Our AccessHope team is very flexible, innovative, and solution-oriented. They bring forth expertise and thought-provoking conversations that drive high-end outcomes needed to support health equity and wrap-around services for cancer care.

The AccessHope team is a true partner. They care about what we care about and always try to help us resolve even some of the most challenging asks. Most importantly, they listen and make us feel valued as a client. We are always reaching higher and for more, and they are along for the ride. Together, we are making a difference.

The proof is in the
(peer-reviewed) paper

Our subspecialists provided evidence-based recommendations that had the potential to influence the treatment plan in approximately 93% of cases.6

Download the study

+-

What is required from me and my client to implement AccessHope?

For our employee-initiated Expert Advisory Review and Cancer Support Team, AccessHope needs an eligibility file.

For our algorithm-based Accountable Precision Oncology service, AccessHope works with health plan/third-party administrator (TPA) operations to proactively initiate case reviews by clinical experts.

+-

How are you different than other cancer support services?

AccessHope’s employer benefit gives employer self-funded plans and the treating physicians of employees remote access to renowned cancer expertise through foundational partnerships with NCI–Designated Comprehensive Cancer Centers, allowing a 100% focus on cancer.

We bring advanced expert knowledge to advise on clinical aspects of a proposed treatment plan and provide evidence-based recommendations including personalized precision medicine opportunities, as well as appropriate clinical trial information and support services, regardless of an employee’s location.

+-

How is AccessHope different than Centers of Excellence (COE) services?

COE services provide medical care to cancer patients; AccessHope does not. AccessHope’s business model remotely connects (a) employees to cancer support services from expert oncology nurses and support staff via our Cancer Support Team; (b) employees’ community oncologists (via our Expert Advisory Review service) and benefit plans (via our Accountable Precision Oncology service) to the latest expertise from NCI–Designated Comprehensive Cancer Centers, eliminating the need to travel for leading cancer expertise and leaving their care decisions 100% in the hands of their local treating physician. Our program supports all cancer types and stages along the member’s journey, while they stay close to home with their local support system.

+-

How are you different than second opinion or expert medical opinion (EMO) services?

Unlike EMO solutions that provide written case reports to members, AccessHope specialists deliver a detailed report on each unique cancer case to the member’s plan or their community oncologist and follow up with an offer of a peer-to-peer clinical consultation call to discuss the evidenced-based recommendations. AccessHope is focused solely on supporting cancer cases with the latest knowledge from NCI centers to help improve quality of life and health outcomes for more people with cancer.

+-

Are community oncologists willing to collaborate with your subspecialists?

Yes. In more than 90% of cases, AccessHope experts offer recommendations which, if adopted by community oncologists, have the potential to influence meaningful and actionable changes to the recommended treatment plan.

In fact, our innovative model of remote expert case reviews was recently validated by a peer-reviewed study in the medical journal JCO Oncology Practice.

+-

How is AccessHope addressing cancer health disparities?

While science continues to evolve, disparities in healthcare based on race and geography persist. AccessHope’s remote approach to Expert Advisory Review and Accountable Precision Oncology services addresses disparities by providing access to NCI expertise regardless of the employee’s geographic location. Highly specialized hospitals like NCI centers have been shown in a study to have higher survival rates over 5 years versus community hospitals.1

As an organization, AccessHope also administers diversity, equity, and inclusion training for their physician, clinical and research teams on empathy, authentic communication, unconscious bias and other related topics.

Reference

1 Pfister DG, Rubin DM, Elkin EB, et al. Risk adjusting survival outcomes in hospitals that treat patients with cancer without information on cancer stage. JAMA Oncol. 2015;1(9)1303-1310.

+-

How do you provide expertise to employees with cancer? Do they need to travel?

AccessHope services do not require members to travel, but instead provide remote access to leading-edge insights.

+-

How do you handle member privacy?

AccessHope values members’ privacy. All employee information is transmitted, used and stored securely, according to applicable HIPAA guidelines.

References:

National Cancer Institute. Data table 3: Reportable patients/participation in therapeutic studies. National Institute of Health Web site. https://cancercenters.cancer.gov/DT/DT3. Accessed June 4, 2021.

2 American Cancer Society. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2020/cancer-facts-and-figures-2020.pdf. Accessed September 8, 2022.

Business Group on Health. 2023 Large Employers’ Health Care Strategy and Plan Design Survey. August 2022. Available at: https://www.businessgrouphealth.org/ resources/2023-large-employers-health-care-strategy-survey-intro

4 American Association for Cancer Research. AACR Cancer Disparities Progress Report 2020. https://cancerprogressreport.aacr.org/wp-content/uploads/sites/2/2020/09/AACR_CDPR_2020.pdf. Published 2020. Accessed October 6, 2020.

5 West HJ, Tan YA, Barzi A, Wong D, Parsley R, Sachs T. Novel program offering remote, asynchronous subspecialist input in thoracic oncology: Early experience and insights gained during the COVID-19 pandemic [published online ahead of print December 3, 2021]. JCO Oncology Practice. doi:10.1200/OP.21.00339